The relationship between inflammatory markers and spirometric parameters in ACOS, Asthma, and COPD-Reference-Cited by-同舟云学术

The relationship between inflammatory markers and spirometric parameters in ACOS, Asthma, and COPD

Published:2019-08-12 Issue:12 Volume:57 Page:1273-1279
ISSN:0277-0903
Container-title:Journal of Asthma
language:en
Short-container-title:Journal of Asthma

Author:

Uzan Gulfidan Cakmak¹^ORCID,Borekci Sermin²^ORCID,Doventas Yasemin Erdogan³,Koldas Macit³,Gemicioglu Bilun²^ORCID

Affiliation:

1. Haseki Training and Research Hospital, Department of Pulmonology, University of Health Sciences, Istanbul, Turkey;

2. Cerrahpasa Medical Faculty, Department of Pulmonary Diseases, Istanbul University-Cerrahpasa, Istanbul, Turkey;

3. Haseki Training and Research Hospital, Department of Biochemistry, University of Health Sciences, Istanbul, Turkey

Publisher

Informa UK Limited

Subject

Pulmonary and Respiratory Medicine,Immunology and Allergy,Pediatrics, Perinatology and Child Health

Link

https://www.tandfonline.com/doi/pdf/10.1080/02770903.2019.1652644

Reference34 articles.

1. Global Strategy for Asthma Management and Prevention. Update 2018. Chapter 5. Diagnosis and initial treatment of asthma. COPD and asthma-COPD Overlap (ACO) 2018; 9298.

2. Mixed Th2 and non-Th2 inflammatory pattern in the asthma–COPD overlap: a network approach

3. Asthma and COPD overlap pathophysiology of ACO

4. Matrix Metalloproteinase-9 in Lung Remodeling

5. Exhaled leukotrienes and prostaglandins in COPD

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Contemporary Biomarkers in Severe Asthma Management;J BIOL REG HOMEOS AG;2024

2. Vaccination against respiratory tract pathogens in primary immune deficiency patients receiving immunoglobulin replacement therapy;TUBERK TORAK;2024

3. Unraveling the Pathogenesis of Asthma and Chronic Obstructive Pulmonary Disease Overlap: Focusing on Epigenetic Mechanisms;Cells;2022-05-24

4. Asthma-COPD overlap;The Nurse Practitioner;2022-02

5. Concepts of advanced therapeutic delivery systems for the management of remodeling and inflammation in airway diseases;Future Medicinal Chemistry;2022-02